Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 9:00 PM View:  | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 15-Mar-24 | Grant | 3,166 | $4.54 | $14,373.60 | < 1% 4.5M to 4.5M | (< 1%) |
| 03-Apr-24 8:49 PM View: | Dixon Wendy L Director | Black Diamond Therapeutics,... (BDTX) | 15-Mar-24 | Grant | 3,253 | $4.54 | $14,768.60 | 9% 34.8K to 38.05K | (< 1%) |
| 15-Dec-23 4:40 PM View: | Dixon Wendy L Director | Black Diamond Therapeutics,... (BDTX) | 15-Dec-23 | Grant | 4,043 | $2.73 | $11,037.40 | 13% 30.76K to 34.8K | |
| 15-Dec-23 4:48 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 15-Dec-23 | Grant | 4,455 | $2.73 | $12,162.20 | < 1% 4.49M to 4.5M | |
| 19-Oct-23 3:08 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 17-Oct-23 | Private Purchase | 400,000 | $2.34 | $934,080.00 | 5% 8.12M to 8.52M | |
| 18-Sep-23 5:26 PM View: | Velleca Mark A. PRESIDENT & CEO Director | Black Diamond Therapeutics,... (BDTX) | 15-Sep-23 | Grant | 5,208 | $3.60 | $18,748.80 | 13% 41.31K to 46.52K | |
| 18-Sep-23 5:34 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 15-Sep-23 | Grant | 3,299 | $3.60 | $11,876.40 | < 1% 4.49M to 4.49M | |
| 18-Sep-23 5:25 PM View: | Dixon Wendy L Director | Black Diamond Therapeutics,... (BDTX) | 15-Sep-23 | Grant | 2,986 | $3.60 | $10,749.60 | 11% 27.77K to 30.76K | |
| 06-Jul-23 4:45 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 05-Jul-23 | Market Purchase | 1,000,000 | $5.00 | $5,000,000.00 | 29% 3.49M to 4.49M | (10%) |
| 07-Jul-23 4:30 PM View: | Ra Capital Management, LLC Director | Black Diamond Therapeutics,... (BDTX) | 05-Jul-23 | Market Purchase | 935,850 | $5.00 | $4,679,250.00 | 36% 2.59M to 3.53M | (10%) |
| 03-Jul-23 3:36 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 30-Jun-23 | Market Purchase | 1,000,000 | $5.00 | $5,000,000.00 | 14% 7.12M to 8.12M | (10%) |
| 29-Jun-23 1:37 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 27-Jun-23 | Market Purchase | 1,740,000 | $5.49 | $9,555,040.00 | 32% 5.38M to 7.12M | (18%) |
| 28-Jun-23 4:02 PM View: | Epstein David M. See Remarks Director | Black Diamond Therapeutics,... (BDTX) | 27-Jun-23 | Private Sale (Planned) | 25,000 | $6.70 | $167,500.00 | (3%) 961.57K to 936.57K | |
| 20-Mar-23 4:33 PM View: | Velleca Mark A. Director | Black Diamond Therapeutics,... (BDTX) | 16-Mar-23 | Grant | 11,228 | $1.67 | $18,750.80 | 53% 21.16K to 32.38K | |
| 20-Mar-23 4:41 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 16-Mar-23 | Grant | 7,111 | $1.67 | $11,875.40 | < 1% 3.48M to 3.48M | |
| 20-Mar-23 4:34 PM View: | Dixon Wendy L Director | Black Diamond Therapeutics,... (BDTX) | 16-Mar-23 | Grant | 6,437 | $1.67 | $10,749.80 | 40% 16.22K to 22.65K | |
| 15-Feb-23 4:11 PM View: | Jones Erika See Remarks | Black Diamond Therapeutics,... (BDTX) | 13-Feb-23 | Grant | 5,075 | -- | -- | 100% 5.08K to 10.15K | |
| 23-Dec-22 4:23 PM View: | Ni Fang See Remarks | Black Diamond Therapeutics,... (BDTX) | 22-Dec-22 | Purchase | 36,363 | $1.28 | $46,595.50 | 41% 89.03K to 125.39K | |
| 23-Dec-22 4:23 PM View: | Ni Fang See Remarks | Black Diamond Therapeutics,... (BDTX) | 21-Dec-22 | Private Purchase | 20,000 | $1.29 | $25,770.00 | 29% 69.03K to 89.03K | |
| 19-Dec-22 9:14 PM View: | Ingram Robert Alexander | Black Diamond Therapeutics,... (BDTX) | 16-Dec-22 | Grant | 9,375 | $1.50 | $14,062.50 | 28% 33.48K to 42.85K | |
| 19-Dec-22 9:16 PM View: | Velleca Mark A. Director | Black Diamond Therapeutics,... (BDTX) | 16-Dec-22 | Grant | 8,424 | $1.50 | $12,636.00 | 66% 12.73K to 21.16K | |
| 19-Dec-22 9:27 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 16-Dec-22 | Grant | 7,917 | $1.50 | $11,875.50 | < 1% 3.47M to 3.48M | |
| 19-Dec-22 9:15 PM View: | Dixon Wendy L Director | Black Diamond Therapeutics,... (BDTX) | 16-Dec-22 | Grant | 7,167 | $1.50 | $10,750.50 | 79% 9.05K to 16.22K | |
| 02-Nov-22 3:10 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 31-Oct-22 | Private Purchase | 99,801 | $2.25 | $224,912.00 | 2% 5.28M to 5.38M | |
| 31-Oct-22 3:20 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 28-Oct-22 | Purchase | 172,974 | $2.18 | $376,962.00 | 3% 5.11M to 5.28M | |
| 31-Oct-22 3:20 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 27-Oct-22 | Private Purchase | 191,678 | $1.87 | $359,224.00 | 4% 4.91M to 5.11M | |
| 25-Oct-22 4:24 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 21-Oct-22 | Private Purchase | 87,850 | $1.51 | $132,750.00 | 2% 4.83M to 4.91M | |
| 21-Oct-22 3:06 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 20-Oct-22 | Purchase | 53,734 | $1.42 | $76,345.30 | 1% 4.77M to 4.83M | |
| 21-Oct-22 3:06 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 19-Oct-22 | Private Purchase | 77,689 | $1.32 | $102,775.00 | 2% 4.69M to 4.77M | |
| 19-Sep-22 5:08 PM View: | Ingram Robert Alexander Director | Black Diamond Therapeutics,... (BDTX) | 16-Sep-22 | Grant | 6,584 | $2.62 | $17,250.10 | 24% 26.89K to 33.48K | |
| 19-Sep-22 5:09 PM View: | Velleca Mark A. Director | Black Diamond Therapeutics,... (BDTX) | 16-Sep-22 | Grant | 4,294 | $2.62 | $11,250.30 | 51% 8.44K to 12.73K | |
| 19-Sep-22 6:39 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 16-Sep-22 | Grant | 4,532 | $2.62 | $11,873.80 | < 1% 3.46M to 3.47M | |
| 19-Sep-22 5:10 PM View: | Dixon Wendy L Director | Black Diamond Therapeutics,... (BDTX) | 16-Sep-22 | Grant | 4,103 | $2.62 | $10,749.90 | 83% 4.95K to 9.05K | |
| 30-Jun-22 4:05 PM View: | Ni Fang See Remarks | Black Diamond Therapeutics,... (BDTX) | 29-Jun-22 | Private Purchase | 25,000 | $2.44 | $61,017.50 | 57% 44.03K to 69.03K | |
| 17-Jun-22 4:25 PM View: | Ingram Robert Alexander Director | Black Diamond Therapeutics,... (BDTX) | 17-Jun-22 | Grant | 8,498 | $2.03 | $17,250.90 | 46% 18.4K to 26.89K | |
| 17-Jun-22 4:27 PM View: | Velleca Mark A. Director | Black Diamond Therapeutics,... (BDTX) | 17-Jun-22 | Grant | 5,542 | $2.03 | $11,250.30 | 191% 2.9K to 8.44K | |
| 17-Jun-22 4:35 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 17-Jun-22 | Grant | 5,850 | $2.03 | $11,875.50 | < 1% 3.46M to 3.46M | |
| 17-Jun-22 4:26 PM View: | Dixon Wendy L Director | Black Diamond Therapeutics,... (BDTX) | 17-Jun-22 | Grant | 4,060 | $2.03 | $8,241.80 | 100% 0 to 4.06K | |
| 29-Apr-22 10:50 AM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 28-Apr-22 | Purchase | 255,711 | $2.57 | $657,868.00 | 6% 4.44M to 4.69M | |
| 29-Apr-22 10:50 AM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 27-Apr-22 | Private Purchase | 150,000 | $2.66 | $399,480.00 | 3% 4.29M to 4.44M | |
| 20-Apr-22 12:56 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 19-Apr-22 | Purchase | 150,000 | $3.24 | $486,645.00 | 4% 4.14M to 4.29M | |
| 20-Apr-22 12:56 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 18-Apr-22 | Private Purchase | 150,000 | $3.29 | $493,935.00 | 4% 3.99M to 4.14M | |
| 14-Apr-22 12:09 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 13-Apr-22 | Purchase | 102,556 | $3.57 | $366,217.00 | 3% 3.89M to 3.99M | |
| 14-Apr-22 12:09 PM View: | Biotech Growth N V 10% Owner | Black Diamond Therapeutics,... (BDTX) | 12-Apr-22 | Private Purchase | 150,000 | $3.42 | $513,600.00 | 4% 3.74M to 3.89M | |
| 18-Mar-22 4:05 PM View: | Ingram Robert Alexander Director | Black Diamond Therapeutics,... (BDTX) | 18-Mar-22 | Grant | 5,795 | $3.02 | $17,500.90 | 46% 12.6K to 18.4K | |
| 18-Mar-22 4:05 PM View: | Velleca Mark A. Director | Black Diamond Therapeutics,... (BDTX) | 18-Mar-22 | Grant | 2,897 | $3.02 | $8,748.94 | 100% 0 to 2.9K | |
| 18-Mar-22 4:15 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 18-Mar-22 | Grant | 4,346 | $3.02 | $13,124.90 | < 1% 3.45M to 3.46M | |
| 17-Feb-22 4:17 PM View: | Jones Erika See Remarks | Black Diamond Therapeutics,... (BDTX) | 15-Feb-22 | Grant | 5,075 | -- | -- | 100% 0 to 5.08K | |
| 17-Dec-21 4:50 PM View: | Behbahani Ali Director | Black Diamond Therapeutics,... (BDTX) | 17-Dec-21 | Grant | 2,472 | $5.31 | $13,126.30 | < 1% 3.45M to 3.45M | (2%) |
| 17-Dec-21 4:12 PM View: | Ingram Robert Alexander Director | Black Diamond Therapeutics,... (BDTX) | 17-Dec-21 | Grant | 3,296 | $5.31 | $17,501.80 | 35% 9.31K to 12.6K | 0% |
